Company intelligence / Profile preview

ProSpec

Rehovot, Central District, Israelprospecbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

ProSpec is an established global supplier of over 6,000 recombinant proteins, peptides, antibodies and related products used in life science research. Their products are widely used in academic labs as well as biotech/pharma R&D settings for applications such as cancer biology, immunology, neuroscience and stem cell research. The company emphasizes high purity standards and biological activity in its offerings.

Therapeutic areas: Other
Modalities: Recombinant proteinPeptidesAntibodyEnzyme
Industry: Chemicals & Materials

Partnerships

Collaborates with academic researchers globally to expand product portfolioSeeks distribution partners worldwide

Beyond the preview

Go deeper on ProSpec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProSpec.

Explore the full profile